Global Med Technologies(R) to Present at Rodman & Renshaw 9th Annual Healthcare Conference
November 01 2007 - 9:00AM
PR Newswire (US)
DENVER, Nov. 1 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will be presenting at the Acumen Biofin Rodman & Renshaw 9th
Annual Healthcare Conference to be held November 5-7 at the New
York Palace Hotel in New York City. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) On
Tuesday, November 6th, at 11:15 a.m. EST, Dr. Michael Ruxin, Chief
Executive Officer of Global Med Technologies, will give a 20-minute
presentation in the Spellman Room, regarding Global Med's business
and discuss its unique value proposition, latest developments,
financial performance and prospects. Management will also
participate in a question and answer session following the
presentation and in one-on-one meetings throughout the day. The
Acumen Biofin Rodman & Renshaw Healthcare Conference will
include presentations by over 350 companies, as well as experts
from the medical, scientific and investment communities. The
categories of presentation include autoimmune diseases,
cardiovascular diseases, CNS, drug delivery, gene therapy,
infectious diseases, medical devices, oncology, specialty
pharmaceuticals, and therapeutic vaccines. A vast number of
Investors, venture capitalists, company executives, scientists and
other industry leaders are expected to attend. About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: company contact, Michael I. Ruxin, M.D., of Global
Med Technologies, Inc., +1-303-238-2000; or investor contact, Paul
Holm of H.L. Lanzet, +1-212-888-4570, , for Global Med
Technologies, Inc. Web site: http://www.globalmedtech.com/
Copyright